Belite Bio, Inc
NASDAQ:BLTE · NASDAQ Capital Market
+$0.46 today
Vol 0.25M · Avg 0.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+137.59%
Period High
$190.30
Period Low
$56.81
Latest
$146.12
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.92B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.36B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.29B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.78B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.71B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.61B
Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT
$3.28B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.24B
Soleno Therapeutics, Inc.
SLNO
$2.76B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.97B
What is the latest BLTE filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does BLTE have?
Intrinsic Alpha currently shows 20 recent filings for BLTE.
Explore More
Continue the stock analysis
Jump to another research area for this company.